Search results for "cancer diagnosis"

Find out why PROTACs hold such promise in cancer drug discovery

RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses

New Seven Color Multiplexing and Visualization Tools Help Accelerate Cancer Research

New NGS products for streamlined sample prep and ovarian cancer research

Syngeneic urothelial carcinoma model for bladder cancer research and immunotherapy development

ToRCH is an acronym for a group of infectious agents that include Toxoplasma, Rubella, Cytomegalovirus (CMV), and Herpes. When acquired during pregnancy these agents can cause significant birth defects and fetal death. Recognizing maternal disease and monitoring the patient when diagnosed is critical for clinicians and patients. Siemens Healthineers portfolio of ToRCH and specialty assays is designed with the latest technol…

New hematologic biomarker has the potential to revolutionize clinicians’ approach to sepsis triage and diagnosis

New biomarker evaluates the biologic activity of blockbuster breast cancer drug Ibrance

Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples

New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs

Cysteine-containing protein modifier; Inhibits growth of triple-negative breast cancer cells

Obtain continuous measurements in water extraction and other applications

Pre-Term Preeclampsia Project “ASPRE” Study Utilized PerkinElmer’s DELFIA Xpress PlGF 1-2-3 Assay to Identify Women who Would Benefit from Low-Dose Aspirin

Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs

(This is suggested replacement for 3001.) 225cm2 available growth area Manufactured from optically clear virgin polystyrene Treated for optimal cell attachment Printed with lot numbers for ease in traceability 100% integrity tested Sterilized by gamma irradiation Nonpyrogenic